Literature DB >> 19760636

No association between variant DNA repair genes and prostate cancer risk among men of African descent.

Nicole A Lavender1, Oyeyemi O Komolafe, Marnita Benford, Guy Brock, Jason H Moore, Tiva T Vancleave, J Christopher States, Rick A Kittles, La Creis R Kidd.   

Abstract

BACKGROUND: Recent reports hypothesize that multiple variant DNA repair gene interactions influence cancer susceptibility. However, studies identifying high-risk cancer-related genes use single gene approaches that lack the statistical rigor to model higher order interactions.
METHODS: To address this issue, we systematically evaluated individual and joint modifying effects of commonly studied polymorphic base and nucleotide excision repair genes relative to prostate cancer (PCA) risk using conventional logistic regression models and multifactor dimensionality reduction (MDR). We hypothesized that inheriting two or more compromised DNA repair loci may increase PCA risk due to altered gene product function. Six genetic alterations were evaluated using germ-line DNA samples from 208 PCA cases and 665 disease-free controls via TaqMan polymerase chain reaction.
RESULTS: With the exception of XPD 312, no association existed between individual DNA repair single-nucleotide polymorphisms (SNPs) and PCA. Individuals with the XPD 312 Asn/Asn genotype had an 8.6-fold increase in risk (OR = 8.59; 95% CI = 1.81-40.66). We did not observe any significant single gene or gene-gene interactions based on MDR modeling.
CONCLUSIONS: Our findings emphasize the importance of utilizing a combination of traditional and advanced statistical tools to identify and validate single gene and multilocus interactions in relation to cancer susceptibility.

Entities:  

Mesh:

Year:  2010        PMID: 19760636      PMCID: PMC2798907          DOI: 10.1002/pros.21048

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  38 in total

1.  Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study.

Authors:  Leah E Mechanic; Robert C Millikan; Jon Player; Allan René de Cotret; Scott Winkel; Kendra Worley; Kristin Heard; Kimberley Heard; Chiu-Kit Tse; Temitope Keku
Journal:  Carcinogenesis       Date:  2006-01-06       Impact factor: 4.944

2.  Polymorphisms of DNA repair genes are risk factors for prostate cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Yuichiro Tanaka; Naoko Okayama; Yutaka Suehiro; Ken Kawamoto; Nobuyuki Kikuno; Shahana Majid; Kaveh Vejdani; Rajvir Dahiya
Journal:  Eur J Cancer       Date:  2006-12-29       Impact factor: 9.162

3.  Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans.

Authors:  Lan Chen; Christine B Ambrosone; Jihyun Lee; Thomas A Sellers; Julio Pow-Sang; Jong Y Park
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

4.  A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping.

Authors:  Chao Tian; David A Hinds; Russell Shigeta; Rick Kittles; Dennis G Ballinger; Michael F Seldin
Journal:  Am J Hum Genet       Date:  2006-08-15       Impact factor: 11.025

5.  DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.

Authors:  Angeline S Andrew; Margaret R Karagas; Heather H Nelson; Simonetta Guarrera; Silvia Polidoro; Sara Gamberini; Carlotta Sacerdote; Jason H Moore; Karl T Kelsey; Eugene Demidenko; Paolo Vineis; Giuseppe Matullo
Journal:  Hum Hered       Date:  2007-09-26       Impact factor: 0.444

6.  Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

Authors:  Shanbeh Zienolddiny; Daniele Campa; Helge Lind; David Ryberg; Vidar Skaug; Lodve Stangeland; David H Phillips; Federico Canzian; Aage Haugen
Journal:  Carcinogenesis       Date:  2005-09-29       Impact factor: 4.944

7.  Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors.

Authors:  Leah E Mechanic; Elise D Bowman; Judith A Welsh; Mohammed A Khan; Nobutoshi Hagiwara; Lindsey Enewold; Peter G Shields; Laurie Burdette; Stephen Chanock; Curtis C Harris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

8.  Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China.

Authors:  Zheng Xu; Li-Xin Hua; Li-Xin Qian; Jie Yang; Xin-Ru Wang; Wei Zhang; Hong-Fei Wu
Journal:  Asian J Androl       Date:  2007-05       Impact factor: 3.285

9.  Association of XPD polymorphisms with prostate cancer in Taiwanese patients.

Authors:  Da-Tian Bau; Hsi-Chin Wu; Chang-Fang Chiu; Cheng-Chieh Lin; Chin-Moo Hsu; Cheng-Li Wang; Rou-Fen Wang; Fuu-Jen Tsai
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

Review 10.  Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Int J Med Sci       Date:  2007-02-01       Impact factor: 3.738

View more
  15 in total

1.  XPD Asp312Asn polymorphism is a risk factor for prostate cancer.

Authors:  Shao-Guang Liao; Lu Liu; Ying Wang; Ying-Yi Zhang; Ya-Jie Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-29       Impact factor: 4.553

2.  Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis.

Authors:  Xin Li; Geng Zhang; Yong-Jun Huai; Zhi-Qiang Cao
Journal:  Tumour Biol       Date:  2014-07-15

3.  The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.

Authors:  Xue Zhou; Li Wei; Guangjun Jiao; Wei Gao; Mingzhen Ying; Ning Wang; Yajie Wang; Chuan Liu
Journal:  Mol Genet Genomics       Date:  2014-09-19       Impact factor: 3.291

4.  XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population.

Authors:  Q I Yang; Yan-Fei Wei; Yuan Zhang; Guang-Mei Huang
Journal:  Exp Ther Med       Date:  2015-04-14       Impact factor: 2.447

5.  Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.

Authors:  Yuanyuan Mi; Lifeng Zhang; Ninghan Feng; Sheng Wu; Xiaoming You; Hongbao Shao; Feng Dai; Tao Peng; Feng Qin; Jiangang Zou; Lijie Zhu
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

6.  Contribution of HOGG1 Ser³²⁶Cys polymorphism to the development of prostate cancer in smokers: meta-analysis of 2779 cases and 3484 controls.

Authors:  Bin Xu; Na Tong; Shu-Qiu Chen; Yu Yang; Xiao-Wen Zhang; Jin Liu; Xiang-Nong Hu; Guo-Zhu Sha; Ming Chen
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

7.  The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.

Authors:  Hongtuan Zhang; Yong Xu; Zhihong Zhang; Liang Li
Journal:  BMC Cancer       Date:  2011-09-13       Impact factor: 4.430

8.  Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.

Authors:  Nicole A Lavender; Erica N Rogers; Susan Yeyeodu; James Rudd; Ting Hu; Jie Zhang; Guy N Brock; Kevin S Kimbro; Jason H Moore; David W Hein; La Creis R Kidd
Journal:  BMC Med Genomics       Date:  2012-04-30       Impact factor: 3.063

Review 9.  Association between the APEX1 Asp148Glu polymorphism and prostate cancer, especially among Asians: a new evidence-based analysis.

Authors:  Yang Chen; Jie Li; Zengnan Mo
Journal:  Oncotarget       Date:  2016-08-09

10.  Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case-control studies.

Authors:  Jie-Hui Zhong; Zhen Zhao; Jie Liu; Hai-Lang Yu; Jue-Yu Zhou; Rong Shi
Journal:  Onco Targets Ther       Date:  2016-03-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.